Dr Apolo on Adjuvant Pembrolizumab in Muscle-Invasive Urothelial Carcinoma
Andrea B. Apolo, MD, discusses the AMBASSADOR Alliance A031501 trial of adjuvant pembrolizumab in locally advanced/muscle-invasive urothelial carcinoma.
Source: onclive.com
Andreab Apolo News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Andreab Apolo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Andreab Apolo Today - Breaking & Trending Today
Adjuvant Pembrolizumab Improves DFS, But Not OS, in Locally Advanced/Muscle-Invasive Urothelial Carcinoma
Adjuvant pembrolizumab generated a disease-free survival benefit vs observation in patients with muscle-invasive and locally advanced urothelial carcinoma.
Source: onclive.com
Advances Across Urothelial Carcinomas Highlight Need for Shared Decision-making
As longer-term data read out for established regimens in urothelial cancer and up-and-coming therapeutics inch toward approval, optimizing treatment approaches relies on buy-in from multidisciplinary teams and patients.
Source: onclive.com